This review challenges the longstanding belief that testosterone supplementation contributes to prostate cancer progression, suggesting that this idea is based on limited and outdated evidence. Despite early studies linking testosterone to prostate cancer growth, more recent research reveals no conclusive evidence that testosterone replacement therapy (TRT) increases prostate cancer risk,
